Professor Perry F. BARTLETT, FAA (Fellow of the
Academic Qualifications
1970 BDSc,
1975 PhD,
Current Appointments
2002 Professor, Chair of Molecular Neuroscience
The
2003 ARC Federation Fellow
Director, Queensland Brain Institute, UQ
Previous Key Appointments
1994- 2002 NHMRC Principal Research Fellow/ Senior Principal Research Fellow Head, Development and Neurobiology Group Walter and Eliza Hall InstituteHonours and Awards
1991 The Inaugural John Woodward Prize for Excellence in Neuroscience, awarded by the
Australian Brain Foundation 2000 Australian Neuroscience Society Plenary Lectureship The Bethlehem-Griffith Research Medal and Prize for Neuroscience 2003 Elected Fellow of theCurrent Major Grants
2003-08 ARC Federation Fellowship, PF Bartlett: $1,475,000 2004-08 NHMRC Program Grant, PF Bartlett, SS Tan, TJ Kilpatrick, P Sah: $6.474 million 2005-08 Spinal CureInternational Profile
Past President, Australian Neuroscience Society (2000-02) Executive Member of the International Brain Organization (IBRO) and the Federation of Asian and Oceanic Neuroscience Societies (FAONS), involved in developing neuroscience education and research policy for the Asia-Pacific Region (2000-02) Member of the Human Frontier Science Program Review Committee (2004-) Frequent invitations to speak at the world’s foremost scientific forums (16 national and 28 international invited presentations in the past 5 years, including 5 plenary lectures) Member of three international editorial boards Member of National Neuroscience Consultative Taskforce (2004- ) Member of the Cellular Therapies Advisory Committee, formerly the Gene Technology Advisory Panel (2003- ).Research Translation
Holder of 81. Coonan JR, Bartlett PF, Galea MP (2003) Role of EphA
14. Merson TD, Rietze RL, Bartlett PF, Thomas T,
15. Fawcett JW, Curt A, Steeves JD, Coleman WP, Tuszynski MH, Lammertse D, Bartlett PF, Blight AR, Dietz V, Ditunno J, Dobkin BH, Havton LA, Ellaway PH, Fehlings MG, Privat A, Grossman R, Guest JD, Kleitman N, Nakamura M, Gaviria M, Short D (2007) Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 45: 190-205.
16. Steeves JD, Lammertse D, Curt A, Fawcett JW, Tuszynski MH, Ditunno JF, Ellaway PH, Fehlings MG, Guest JD, Kleitman N, Bartlett PF, Blight AR, Dietz V, Dobkin BH, Grossman R, Short D, Nakamura M, Coleman WP, Gaviria M, Privat A (2007) Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord 45: 206-221. 17. Tuszynski MH, Steeves JD, Fawcett JW, Lammertse D, Kalichman M, Rask C, Curt A, Ditunno JF, Fehlings MG, Guest JD, Ellaway PH, Kleitman N, Bartlett PF, Blight AR, Dietz V, Dobkin BH, Grossman R, Privat (2007) Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics. Spinal Cord 45: 222-231.18. Coultas L, Terzano S, Thomas T, Voss A, Reid K, Stanley EG, Scott CL, Bouillet P, Bartlett P, Ham J, Adams JM, Strasser A (2007) Hrk/DP5 contributes to the apoptosis of select neuronal populations but is dispensable for haematopoietic cell apoptosis. Journal of Cell Science 120: 2044-2052.
19. Xu ZP,
20. Xu ZP, Walker TL, Lin K, Cooper HM, Lu GQ, Bartlett PF (2007) Layered double hydroxide nanoparticles as cellular delivery vectors of supercoiled plasmid DNA. International Journal of Nanomedicine 2: 163-174.
21. Young KM, Merson TD, Sotthibundhu A, Coulson EJ, Bartlett PF (2007) p75 neurotrophin receptor expression defines a population of BDNF-responsive neurogenic precursor cells. Journal of Neuroscience 27: 5146-5155. Recommended by the Faculty of 1000.
22. Morley SM, Power JM, Coulson EJ, Bartlett PF (2007) Zinc toxicity is dependent on Trk activation Experimental Neurology 205: 360-366.
23. Nandam LS, Jhaveri D, Bartlett P (2007) 5-HT7, neurogenesis and antidepressants: A promising therapeutic axis for treating depression. Clinical and Experimental Pharmacology and Physiology 34: 546-551.
24. Stafford MR, Bartlett PF, Adams DJ (2007) Purinergic receptor activation inhibits mitogen-stimulated proliferation in primary neurospheres from the adult mouse subventricular zone. Molecular and Cellular Neuroscience 35: 535-548.
25. Walker TL, Yasuda T, Adams DJ, Bartlett PF (2007) The doublecortin-expressing population in the developing and adult brain contains multipotential precursors in addition to neuronal-lineage cells. Journal of Neuroscience 27: 3734-3742.
26. Yasuda T, Bartlett PF, Adams DJ Kir and Kv channels regulate electrical properties and proliferation of adult neural precursor cells. Mol Cell Neuroscience 37: 284-297, 2008
27. Underwood CK, Reid K, May LM, Bartlett PF, Coulson EJ. Palmitoylation of the C-terminal fragment of p75NTR regulates death signaling and is required for subsequent cleavage by g-secretase. Mol Cell Neuroscience 37: 346-358, 2008
28. Coulson EJ, May LM, Osborne S, Reid K, Underwood CK, Meunier FA, Bartlett PF, Sah P (2008) p75 neurotrophin receptor mediates neuronal cell death by activating GIRK channels through phosphatidylinositol 4,5-bisphosphate. Journal of Neuroscience 27: 3734-3742.
29. Walker TL,White A, Black DM, Wallace RH, Sah P, Bartlett PF (2008) Latent stem and progenitor cells in the hippocampus are activated by neural excitation. Journal of Neuroscience 28: 5240-5247. (front cover) .

RSS订阅
邮件订阅






